ROBO Global’s HTEC ETF Surpasses $100 Million in Assets Under Management
Fund has returned over 59% to investors year-to-date
Launched in June 2019, HTEC tracks the ROBO Global® Healthcare Technology & Innovation Index, which provides investors with diversified exposure to the most transformative and growth-oriented areas of healthcare, including precision medicine, genomics, telehealth and robotics.
“After closely monitoring the healthcare space for five years as part of our flagship index, it was clear that technological advancements would be reshaping this sector for decades to come,” said Travis Briggs, CEO of ROBO Global, U.S. “It was a natural extension for us to launch a healthcare technology index designed to capture this long-term growth opportunity.”
HTEC has returned over 74%* since inception on June 25, 2019 and over 59% year-to-date (as of 12/15/20).
“HTEC’s performance and asset accumulation are indicators of the growing investor appetite for healthcare innovation,” said Nina Deka, Senior Research Analyst at ROBO Global. “COVID-19 illuminated the need for advanced healthcare technology, like new therapeutics and virtual care. Yet we are still in very early days of adoption, and there is much more innovation to be realized as companies seek to address rising healthcare costs, improve access to care, and ultimately save lives. This presents a tremendous potential opportunity from an investment perspective.”
For more information on ROBO Global ETFs please visit: www.roboglobaletfs.com.
About ROBO Global
ROBO Global is an index, advisory, and research company wholly focused on helping investors capture the unique opportunities of fast-growing robotics, artificial intelligence, and healthcare technology companies around the world. With the expertise of our leadership team and strategic advisors from the industry, we help investors capture the growth and return opportunities presented by innovation across industries, from healthcare to industrials to consumer products. Our indices are used by a variety of investment vehicles listed on multiple exchanges around the world. We are present in Dallas, San Francisco, New York and London. www.ROBOGlobal.com.
Click here for HTEC’s standard performance as of quarter end
Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the original cost.
Exchange Traded Concepts, LLC serves as the investment advisor to the Fund. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Exchange Traded Concepts, LLC or any of its affiliates.
Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found on the Fund’s full or summary prospectus, which may be obtained at www.roboglobaletfs.com. Read the prospectus carefully before investing.
Investing involves risk, including the possible loss of principal. Narrowly focused investments and investments in smaller companies typically exhibit higher volatility. International investments may also involve risk from unfavorable fluctuations in currency values, differences in generally accepted accounting principles, and from economic or political instability. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Diversification may not protect against market risk. Indices are unmanaged. One cannot invest directly in an index. There is no guarantee the fund will achieve its stated objective.
The Fund invests primarily in the equity securities of Medical Technology Companies and, as such, is particularly sensitive to risks to those types of companies. These risks include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation.
Gregory FCA for ROBO Global
Jen Diehl, 610-228-2124